Retirement Guys Formula LLC Purchases 655 Shares of Colgate-Palmolive (NYSE:CL)

Retirement Guys Formula LLC increased its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 9.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,338 shares of the company’s stock after purchasing an additional 655 shares during the period. Retirement Guys Formula LLC’s holdings in Colgate-Palmolive were worth $762,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Diversify Advisory Services LLC purchased a new stake in Colgate-Palmolive during the first quarter valued at approximately $911,000. TD Asset Management Inc increased its holdings in Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after buying an additional 26,987 shares during the last quarter. Empowered Funds LLC increased its holdings in Colgate-Palmolive by 277.3% during the first quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock valued at $2,979,000 after buying an additional 24,314 shares during the last quarter. M&G Plc purchased a new stake in Colgate-Palmolive during the first quarter valued at approximately $3,812,000. Finally, Sei Investments Co. increased its holdings in Colgate-Palmolive by 41.5% during the first quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock valued at $53,901,000 after buying an additional 175,445 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 in the last three months. 0.34% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on CL shares. Bank of America increased their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Stifel Nicolaus increased their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 22nd. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Finally, JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $106.00.

Get Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.9 %

NYSE CL traded down $0.93 during trading on Monday, reaching $99.53. 1,075,956 shares of the company’s stock traded hands, compared to its average volume of 4,324,475. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a market cap of $81.66 billion, a price-to-earnings ratio of 31.79, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. The company’s 50 day simple moving average is $103.43 and its two-hundred day simple moving average is $97.66. Colgate-Palmolive has a 12-month low of $71.46 and a 12-month high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same period last year, the business earned $0.77 EPS. The company’s revenue was up 4.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.